23rd EFMC-YSN MedChemBioOnline
22nd EFMC-YSN MedChemBioOnline
TOPIC: Photopharmacology
Chair: Dr Laia Josa Cullere (Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Spain)
PROGRAMME:
- Keynote Lectures:
- Dr Johannes Broichhagen (Leibniz-Institute for Molecular Pharmacology (FPM), Germany)
- Prof. Nadja A. Simeth-Crespi (Universität Göttingen, Germany)
- Prof. Wiktor Szymanski (University of Groningen, Groningen, The Netherlands)
- Round Table Discussion:
- Dr Johannes Broichhagen (Leibniz-Institute for Molecular Pharmacology (FPM), Germany)
- Prof. Nadja A. Simeth-Crespi (Universität Göttingen, Germany)
- Prof. Wiktor Szymanski (University of Groningen, Groningen, The Netherlands)
- Dr Jana Volaric (Imperial College London, United Kingdom)
What sets EFMC-YSN MedChemBioOnline apart is its flexibility and accessibility. The webinar is free and open to everyone, making it easy to balance your attendance with other commitments. And because it's organised by EFMC-YSN, you'll have the opportunity to connect with a global community of young scientists who share your interests and goals.
We look forward to e-meet you all!
21st EFMC-YSN MedChemBioOnline
PROGRAMME:
Chairman
Dr Jean QUANCARD (NOVARTIS, Switzerland)
Moderator
Dr Chiara BORSARI (University of Milan, Italy)
- 15:30 | Welcome and Introduction
- 15:35 | EFMC Best practices for Medicinal Chemistry
Dr Jean QUANCARD (NOVARTIS, Switzerland) - 15:45 | Targeted Protein Degradation and Bifunctional Molecules (PROTACs and Beyond)
Ms Kirsten MCAULAY (UNIVERSITY OF DUNDEE, United Kingdom) - 16:20 | PROTACs in Clinical Development
Dr Kurt RITTER (UNIVERSITY OF TÜBINGEN, Germany) - 16:35 | Case Study –SMARCA PROTACs
Dr Christiane KOFINK (BOEHRINGER INGELHEIM, Austria) - 17:00 | Roundtable Discussion on "PROTACs - Challenges and Opportunities“
Dr Christiane KOFINK (BOEHRINGER INGELHEIM, Austria)
Ms Kirsten MCAULAY (UNIVERSITY OF DUNDEE, United Kingdom)
Dr Jean QUANCARD (NOVARTIS, Switzerland)
Dr Andrea UNZUE LOPEZ (MERCK HEALTHCARE KGAA,Germany) - 17:30 | End of Webinar
20th EFMC-YSN MedChemBioOnline
TOPIC: Emerging Strategies in Peptide Drug Discovery
Chair: Dr Tilly Bingham (GIO Therapeutics, Switzerland)
Moderator: Dr Sean McKenna (Leiden University, The Netherlands)
PROGRAMME:
- Keynote Lectures:
- Prof. Christian Heinis (EPFL, Switzerland)
- Dr Isabell Kemker (Bayer, Germany)
- Dr Sebastian Pomplun (Leiden University, The Netherlands)
- Round Table Discussion:
- Dr Tilly Bingham (GIO Therapeutics, Switzerland)
- Prof. Christian Heinis (EPFL, Switzerland)
- Dr Isabell Kemker (Bayer, Germany)
- Dr Sebastian Pomplun (Leiden University, The Netherlands)
19th EFMC-YSN MedChemBioOnline
TOPIC: Sustainability in Drug Discovery
Chair: Dr Luc Van Hijfte (Symeres, The Netherlands)
PROGRAMME:
- Keynote Lectures:
- Prof. Magnus J. Johansson (Astrazeneca, Sweden)
- Prof. Benoit Deprez (INSERM/Université de Lille/Institut Pasteur, France)
- Prof. Klaus Kümmerer (Leuphana University, Germany)
- Round Table Discussion:
- Prof. Magnus J. Johansson (Astrazeneca, Sweden)
- Prof. Benoit Deprez (INSERM/Université de Lille/Institut Pasteur, France)
- Prof. Klaus Kümmerer (Leuphana University, Germany)
- Prof. Helen Sneddon (University of York, United Kingdom)
- Prof. Serge Van Calenbergh (Ugent, Belgium)
18th EFMC-YSN MedChemBioOnline
TOPIC: Becoming a Chemical Biologist
Chair: Dr Sean McKenna (Leiden University, The Netherlands)
PROGRAMME:
- Keynote Lectures:
- Prof. Claudia Höbartner (University of Würzburg, Germany)
- Dr Arne Ruffer (F. Hoffmann-La Roche, Switzerland)
- Dr Laura Woodward-Heni (ChemBioChem, Germany)
- Prof. Valle Palomo (Imdea Nanoscience, Spain)
- Round Table Discussion:
- Prof. Claudia Höbartner (University of Würzburg, Germany)
- Dr Sean McKenna(Leiden University, The Netherlands)
- Prof. Valle Palomo (Imdea Nanoscience, Spain)
- Dr Arne Rufer (F. Hoffmann-La Roche, Switzerland)
- Dr Laura Woodward-Heni (ChemBioChem, Germany)
17th EFMC-YSN MedChemBioOnline
TOPIC: Knowledge Creation from Failure
Chair: Dr Tilly BINGHAM (Cumulus Oncology, United Kingdom)
Moderator: Dr Chiara BORSARI (University of Milan, Italy)
PROGRAMME:
- Keynote Lectures:
- Dr Michael Margreiter (Evotec, Germany)
- Dr Gebhard Thoma (Novartis, Switzerland)
- Prof. Daniel Rauh (TU Dortmund University, Germany)
- Round Table Discussion:
- Dr Tilly Bingham (Cumulus Oncology, United Kingdom)
- Dr Stephanie Gueret (AstraZeneca, Sweden)
- Dr Michael Margreiter (Evotec, Germany)
- Dr Gebhard Thoma (Novartis, Switzerland)
- Prof. Daniel Rauh (TU Dortmund University, Germany)
Registration to the event is free and open to all thanks to the generous support of Symeres.
For over 30 years, the world’s leading life sciences companies have made Symeres part of their team. From hit generation and lead optimization, ADME-Tox via our Admescope organization, through to complex route development and clinical supply, we help to create safe, innovative therapies. We make molecules matter. Together.
16th EFMC-YSN MedChemBioOnline
TOPIC: Best Practices in hit-to-lead Optimization
Chair: Dr Chiara BORSARI (University of Milan, Italy)
Moderator: Laia JOSA-CULLERE (Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Spain)
PROGRAMME:
- 16:30 - Welcome and Introduction
- 16:35 - EFMC Best Practices Working Group
- 16:40 - Keynote Lecture: “Best Practices from Hits to Lead Generation – the Output of the EFMC Best Practices Group"
- Dr Rob Young (Blue Burgundy, United Kingdom)
- 17:15 - Symeres Lecture: Design and Optimization of Hits with the Challenge of Targeting two Different Targets
- Dr Anita Wegert (Symeres, The Netherlands)
- 17:25 - Case Study | "The Discovery of Allosteric MALT1 Inhibitor Leads"
- Dr Jean Quancard (Novartis, Switzerland)
- 17:45 - Round Table Discussion: "Best Practices from Hits to Lead Generation"
- Dr Jean Quancard (Novartis, Switzerland)
- Dr Andra Unzue Lopez (Merck, Germany)
- Dr Anita Wegert (Symeres, The Netherlands)
- Dr Rob Young (Blue Burgundy, United Kingdom)
- 18:30 - End of Webinar
Registration to the event is free and open to all thanks to the generous support of Symeres.
For over 30 years, the world’s leading life sciences companies have made Symeres part of their team. From hit generation and lead optimization, ADME-Tox via our Admescope organization, through to complex route development and clinical supply, we help to create safe, innovative therapies. We make molecules matter. Together.
15th EFMC-YSN MedChemBioOnline
TOPIC: New Technologies in Medicinal Chemistry
Chair:
Dr Michele Mari (University of Urbino, Italy)
Moderator:
Dr Sean McKenna (Trinity College Dublin, Ireland)
PROGRAMME:
- Keynote Lecture: "Accelerating Medicinal Chemistry with Electricity"
- Prof. Phil Baran (The Scripps Research Institute, United States)
- "E-lluminating” the Renaissance of Organic Synthesis
- Dr Charles Jiao (IKA, Germany)
- Soft-skill Training | How to Fund Your Research: MSCA Postdoc Fellowships, ERC Starting Grants & Testimonials
- Mrs Paz Yanez-Murillo (University of Antwerp, Belgium)
- Dr Greta Klejborowska (University of Antwerp, Belgium)
- Round Table Discussion: "New Technologies in Medicinal Chemistry"
- Prof. Phil Baran (The Scripps Research Institute, United States)
- Dr Charles Jiao (IKA, Germany)
- Dr Kevin Lam (University of Greenwich, United Kingdom)
- Prof. Lucia Tamborini (University of Milan, Italy)
- Panelist to be announced
The event is free and open to everyone thanks to the support of IKA.
IKA develops and produces state-of-the-art solutions for laboratories and the process industry. To bring even more success to the work of our customers and users, we combine the latest technology with innovative design and think far into the future. Our products are ready for integration into the digital laboratory.
IKA is a responsible family business and at the same time global player. Every day, our more than 900 employees contribute to expanding our leading global market position in laboratory, analytical, and process technology. At our headquarters in Germany, we develop our products and technologies in cooperation with application experts from science and industry, and from there we sell them to more than 160 countries.

14th EFMC-YSN MedChemBioOnline
TOPIC: Successful Stories of Women in Science: Inspiring Career Paths
Chair:
Dr Chiara BORSARI (University of Milan, Italy)
Moderator:
Dr Caroline LANTHIER (University of Antwerp, Belgium)
PROGRAMME:
- 16:30 | Welcome and Introduction
- 16:35 | Addressing Underexplored Anti-infective Targets
Prof. Anna K. H. Hirsch (Helmholtz Institute for Pharmaceutcial Research Saarland, Germany) - 17:10 | Communication is not only for the Public
Dr Elodie Chabrol (Freelance Science Communicator, France) - 17:45 | Round Table Discussion: "Challenges and Opportunities for Women in STEM"
- Prof. Anna K. H. Hirsch (Helmholtz Institute for Pharmaceutcial Research Saarland, Germany)
- Dr Elodie Chabrol (Freelance Science Communicator, France)
- Prof. Zaneta Nikolovska-Coleska (University of Michigan, United States)
- Dr Radka Snajdrova (Novartis Pharma AG, Switzerland)
- Dr Wendy Young (MPM Capital, United States)
- 18:30 | End of the Webinar
The event is free and open to everyone thanks to the support of Journal of Medicinal Chemistry and ACS Medicinal Chemistry Letters.
The Journal of Medicinal Chemistry and ACS Medicinal Chemistry Letters are published by ACS Publications, a nonprofit society publisher and a division of the American Chemical Society. ACS also supports the global community of scientific researchers through digital books and courses from the ACS Institute.
13th EFMC-YSN MedChemBioOnline
TOPIC: Chemical Biology as a Bridge Between Industry and Academia
Chairs:
Dr Maria DUCA (University of Côte d'Azur, France) @EFMC Chemical Biology Initiative
Dr Clemens ZWERGEL (University of Rome "La Sapienza", Italy) @EFMC Young Scientists Network
PROGRAMME:
- Explorations in Chemical Biology
Prof. Boris Vauzeilles (Institut de Chimie des Substances Naturelles, France) - Precision Chemistry applied to Chemical Biology Tools
Dr Luc Van Hijfte (Symeres, The Netherlands) - Cross-Fertilization of Industrial Drug Discovery and Academic Research – Examples from the Discovery of Cannabinoid Receptor Type 2 Agonist RG7774
Dr Uwe Grether (F. Hoffmann-La Roche, Switzerland) - Round Table Discussion: "The Stories Behind the Chemical Biologists"
Dr Maria Duca (Côte d'Azur University, France)
Dr Sebastian Essig (Bayer, Germany)
Dr Uwe Grether (F. Hoffmann-La Roche, Switzerland)
Prof. Boris Vauzeilles (Institut de Chimie des Substances Naturelles, France)
Dr Luc Van Hijfte (Symeres, The Netherlands)
Registration to the event is free and open to all thanks to the generous support of Symeres.
For over 30 years, the world’s leading life sciences companies have made Symeres part of their team. From hit generation and lead optimization, ADME-Tox via our Admescope organization, through to complex route development and clinical supply, we help to create safe, innovative therapies. We make molecules matter. Together.
12th EFMC-YSN MedChemBioOnline
TOPIC: Covalent Chemical Probes and Drugs
Chair
Dr Chiara BORSARI (University of Basel, Switzerland)
Moderator
Dr Caroline LANTHIER (University of Antwerp, Belgium)
PROGRAMME:
- What Makes Drug Discovery Teams Successful?
Dr Mark Murcko (Dewpoint Therapeutics, United States) - The Discovery of Covalent Hits using DNA-Encoded Library Technology
Dr Andreas Schoop (WuXi AppTec, Germany) - Covalent Inhibitors Targeting the Protein Kinases’ Cysteinome
Dr Matthias Gehringer (University of Tübingen, Germany) - Round Table Discussion on Designing Irreversible Inhibitors: Advantages and Challenges, with experts in the fields
Dr Simona Cotesta (Novartis, Switzerland)
Dr Matthias Gehringer (University of Tübingen, Germany)
Prof. Nir London (Weizmann Institute of Science, Israel)
Prof. Rui Moreira (University of Lisbon, Portugal)
Registration to the event is free and open to all thanks to the generous support of WuXi AppTec.
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients.

11th EFMC-YSN MedChemBioOnline
TOPIC: Late Stage Functionalisation
Chair
Dr Michele MARI (University of Urbino Carlo Bo, Italy)
PROGRAMME:
- Late-Stage C-H Functionalization of Arenes
Prof. Tobias Ritter (Max-Planck-Institut für Kohlenforschung, Germany) - Sponsor Lecture
- Peer Review: Best Practices and Insights for Referees & Authors
Dr David Peralta (ChemMedChem, Germany) - Round Table Discussion: "Integrity of Data and Peer Reviewing in MedChem and ChemBio"
Prof. Erick M. Carreira (ETH Zürich, Switzerland)
Prof. Stuart Conway (University of Oxford, United Kingdom)
Dr Maria Duca (University of Côte d'Azur, France)
Prof. Antonello Mai (University of Rome, Italy)
Dr David Peralta (ChemMedChem, Germany)
10th EFMC-YSN MedChemBioOnline
TOPIC: What Can the Medicinal Chemists Learn from Data Sciences?
Chairs
Dr Filipa RAMILO GOMES (F. Hoffmann-La Roche, Switzerland) @ EFMC Young Scientists Network
Dr Franz VON NUSSBAUM (Nuvisan, Germany) @ EFMC² Computational Chemistry Initiative
PROGRAMME:
- 17:00 | Opening
- 17:05 | Data Science in Medicinal Chemistry: Evolution or Revolution?
Dr Nikolaus Stiefl (Novartis, Switzerland) - 17:50 | Data Science, AI, ML and Drug Discovery: Symeres' Point of View.
Dr Rutger Folmer (Symeres, The Netherlands) - 18:00 | Practical Cheminformatics With Open Source Software
Dr Pat Walters (Relay Therapeutics, United States) - 18:45 | Round Table Discussion: "What Can the Medicinal Chemists Learn from Data Sciences?"
Dr Zoe Cournia (Biomedical Research Foundation, Academy of Athens, Greece)
Dr Rutger Folmer (Symeres, The Netherlands)
Dr Natalja Kurbatova (Zifo RnD Solutions, Switzerland)
Dr Victor Sebastian Perez (Exscientia, United Kingdom)
Dr Nikolaus Stiefl (Novartis, Switzerland)
Dr Pat Walters (Relay Therapeutics, United States) - 19:15 | End
Registration to the event is free and open to all thanks to the generous support of Symeres.
For over 30 years, the world’s leading life sciences companies have made Symeres part of their team. From hit generation and lead optimization, ADME-Tox via our Admescope organization, through to complex route development and clinical supply, we help to create safe, innovative therapies. We make molecules matter. Together.
9th EFMC-YSN MedChemBioOnline
TOPIC: Biological Testing of Hit Compounds
Chair
Dr Chiara BORSARI (University of Basel, Basel, Switzerland)
Moderator
Ms Marta PIQUERO (University of Basel, Basel, Switzerland)
PROGRAMME:
- 17:00 | Opening
- 17:05 | Introduction to the European Lead Factory
Dr Vera NIES (European Lead Factory, together with Lygature, The Netherlands) - 17:20 | Sponsor Presentation: Pivot Park Screening Centre
- 17:25 | Best practices in High Throughput Screening: ELF as an example
Dr Steven VAN HELDEN (Pivot Park Screening Centre, The Netherlands) - 17:55 | Approaches Towards PAINSless Lead Generation
Dr Phil JONES (BioAscent, United Kingdom) - 18:35 | Sponsor Presentation: Servier
- 18:40 | Identification of MALT1 Protease Inhibitors by High Throughput Screening
Dr Jean QUANCARD (Novartis, Switzerland) - 19:15 | End of the Event
The event is free and open to all thanks to the generous support of our sponsors.
![]() |
![]() |
|
Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery. At PPSC we provide drug discovery services in Assay Development, ultra-High-Throughput Screening (uHTS), Mass Spectrometry Screening and Hit-to-lead Profiling to find novel leads for drug development. PPSC is located at Pivot Park Life Sciences Campus in Oss, The Netherlands. Learn more at https://www.ppscreeningcentre.com/ |
Servier is a global pharmaceutical group governed by a Foundation, with a strong international presence in 150 countries and 22,500 employees worldwide. A leader in cardiology, our ambition is to become a renowned and innovative player in oncology for the benefit of patients.
The Group is committed to open and collaborative innovation with academia, pharmaceutical groups, and biotech companies. More information: servier.com |
8th EFMC-YSN MedChemBioOnline
TOPIC: Validating Chemical Probes
Chairman
Dr Etienne Donckele (Monte Rosa Therapeutics, Switzerland)
Moderator
Matic Proj (University of Ljubljana, Slovenia)
PROGRAMME:
- 17:00 | Opening
Dr Etienne Donckele (Monte Rosa Therapeutics, Switzerland) - 17:05 | opnMe.com: the Boehringer Ingelheim´s Open Innovation Portal to Foster Innovation by Openly Sharing Probe Compounds | Video
Dr Florian Montel (Boehringer Ingelheim, Germany) - 17:50 | Innovation in Precision Chemistry for Identification of Novel Chemical Probes | Video
Dr Ton Vries (Symeres, The Netherlands) - 18:00 | Sympathy for the Methyl: A Library-on-library Screening Approach to Identify Chemical Probes for Methyl-lysine Reader Proteins | Video
Prof. Gianluca Sbardella (University of Salerno, Italy) - 18:45 | Round Table Discussion: "Is There a Rule of Thumb for Selecting Chemical Probes?" | Video
Dr Russell Craft (Symeres, The Netherlands)
Dr Stéphanie Guéret (AstraZeneca, Sweden)
Prof. Stefan Laufer (Tuebingen University, Germany)
Dr Florian Montel (Boehringer Ingelheim, Germany)
Prof. Gianluca Sbardella (University of Salerno, Italy) - 19:15 | End of the event
The event is free and open to all thanks to the generous support of Symeres.
Symeres is the leading mid-sized European Contract Research Organization for your drug discovery and development needs. With over 500 scientists, we offer best-in-class solutions from early-stage hit finding to the delivery of your early clinical drug substance API, for small- to medium-sized molecules.
7th EFMC-YSN MedChemBioOnline
TOPIC: Present and Future of Epigenetics
Chairman
Dr Clemens Zwergel (Sapienza University of Rome, Italy)
Moderator
Dr Caroline Lanthier (University of Antwerp, Belgium)
PROGRAMME:
- 17:00 | Opening
- 17:05 | Chemical Probes in Target Discovery
Prof. Paul Brennan (University of Oxford, United Kingdom) | Abstract & Biography - 17:50 | Enabling Epigenetic Drug Discovery Through Quality Proteins and Assay Services
Dr Ekaterina Kuznetsova (Reaction Biology, United States) | Biography - 18:00 | Publishing Ethics: Best Practices in Writing Manuscripts
David Peralta (Editor-in-Chief, ChemMedChem, A Chemistry Europe Journal) | Abstract & Biograpghy - 18:45 | Round Table Discussion: "Epigenetics the Road Ahead: Are Polypharmacology and Epitranscriptomics our Bright Future?“
Prof. Paul Brennan (University of Oxford, United Kingdom) | Biography
Dr Haiching Ma (Reaction Biology, United States) | Biography
Prof. Gianluca Sbardella (University of Salerno, Italy) | Biography
Prof. Olalla Vazquez (Philipps-University Marburg, Germany) | Biography - 19:15 | End of the event
The event will be free and open to all thanks to the generous support of Reaction Biology.

Reaction Biology is an industry leader offering contract research for epigenetic drug discovery. We have a reputation for providing high quality data generated by gold standard activity and binding assays. Via flexibility for custom-tailored solutions and direct communication with our clients we address the goals of every individual research project.
6th EFMC-YSN MedChemBioOnline
TOPIC: PROTAC and Small Molecules Development
Chairwoman
Dr Chiara Borsari (University of Basel, Switzerland)
Moderator
Mr Matic Proj (University of Ljubljana, Slovenia)
PROGRAMME:
- 17:00 | Opening
- 17:05 | Targeted protein degradation with small molecules: How PROTACs work (Replay unavailable)
Prof. Alessio Ciulli (University of Dundee, United Kingdom) | Abstract & Biography - 17:50 | Precision Chemistry applied to PROTACs (Watch the replay)
Dr Luc Van Hijfte (Symeres, The Netherlands) | Abstract & Biography - 18:00 | Controlling Physicochemical Properties in Drug Design (Watch the replay)
Dr Klemens Hoegenauer (Novartis, Switzerland) | Abstract & Biography - 18:45 | Round Table discussion on "Challenges and Opportunities in PROTAC vs Small Molecules Development" (Watch the replay)
Prof. Alessio Ciulli (University of Dundee, United Kingdom)
Dr Danette Daniels (Promega, United States) | Biography
Dr Rutger Folmer (Symeres, The Netherlands) | Biography
Dr Klemens Hoegenauer (Novartis, Switzerland)
Dr Malin Lemurell (AstraZeneca, Sweden) | Biography
Dr Georg Winter (Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria) | Biography - 19:15 | End of the event
The event was generously supported by Symeres.
Symeres is the leading mid-sized European Contract Research Organization for your drug discovery and development needs. With over 500 scientists, we offer best-in-class solutions from early-stage hit finding to the delivery of your early clinical drug substance API, for small- to medium-sized molecules.
5th EFMC-YSN MedChemBioOnline
TOPIC: Artificial Intelligence applied to Medicinal Chemistry
Chairwoman
Dr Kristina Goncharenko (Spirochem, Switzerland)
Moderator
Dr Filipa Ramilo Gomes (Instituto Superior Técnico, University of Lisbon, Portugal)
PROGRAMME:
- 17:00 | Opening
- 17:05 | Integration of AI in Medicinal Chemistry: Practical Applications & Challenges
Dr Christian Tyrchan (AstraZeneca, Sweden) | Abstract & Biography - 17:50 | Schrödinger's Computational Molecular Design Platform
Dr Thomas Steinbrecher (Schrödinger, Germany) | Abstract & Biography - 18:00 | Computational Chemistry in an Industrial Setting in the 21st Century
Dr Jas Bhachoo (Schrödinger, Germany) | Abstract & Biography - 18:45 | Round Table Discussion: "Artificial Intelligence in Medicinal Chemistry, what's next?"
Prof. Jürgen Bajorath (university of Bonn, Germany) | Biography
Prof. Ana Newton (Yale University, United States) | Biography
Dr Thomas Steinbrecher (Schrödinger, Germany)
Dr Nikolaus Stiefl (Novartis, Switzerland) | Biography
Dr Christian Tyrchan (AstraZeneca, Sweden) - 19:15 | End of the Meeting
The event was generously sponsored by Schrödinger.
To improve human health and quality of life by transforming the way therapeutics and materials are discovered.
4th EFMC-YSN MedChemBioOnline
PROGRAMME:
Chairwoman
Dr Filipa Ramilo Gomes (Instituto Superior Técnico, University of Lisbon, Portugal)
Moderator
Dr Leire Iralde Lorente (University of Siena, Italy)
- 17:00 | Opening
- 17:05 | Tools and Drugs to Target Purinergic Signalling for Cancer Immunotherapy
Prof. Christa Müller (University of Bonn, Germany) - 18:00 | Women in Medicinal Chemistry: Per Aspera Ad Astra | Video
- Prof. Maria Laura Bolognesi (University of Bologna, Italy)
- 18:30 | Round Table discussion - "Gender Balance in Medicinal Chemistry: How can we do better?" | Video
Prof. Yimon Aye (EPFL, Switzerland)
Prof. Maria Laura Bolognesi (University of Bologna, Italy)
Dr Sharon Bryant (Inte:ligand GmbH, Austria)
Prof. Rui Moreira (University of Lisbon & EFMC, Portugal)
Prof. Christa Müller (University of Bonn, Germany)
Prof. Maud Reiter (Firmenich, Switzerland) - 19:15 | End of the meeting
3rd EFMC-YSN MedChemBioOnline
Chairwoman
Dr Kristina Goncharenko (Spirochem, Switzerland)
Moderator
Mrs Caroline Lanthier (University of Caen Normandy, France)
PROGRAMME:
- 17:00 | Opening
- 17:05 | Route Scouting for Kilogram-Scale Manufacturing of API’s: Brain Breaker for Real Organic Chemists Abstract | Video
Dr Martin Strack (MercachemSyncom, The Netherlands) - 17:50 | Cartridge-based Automated Synthesis – A New Tool for the Synthetic Chemist Abstract | Video
Dr Benedikt Wanner (Synple Chem, Switzerland) - 18:00 | How to Present Confidently in Online Meetings Abstract | Markus' website
Mr Markus Seppälä (Event host & Comedian, Switzerland) - 18:45 | Round Table discussion - "Confused after Graduation? Don't get lost in your Career Path!" | Video
Prof. Roberto Pellicciari (University of Perugia & TES Pharma, Italy)
Prof. Tracey Pirali (University of Piemonte Orientale & ChemIcare, Italy)
Dr Martin Strack (MercaChemSyncom, The Netherlands)
Dr Giulio Volpin (Bayer, Germany)
Dr Benedikt Wanner (Synple Chem, Switzerland)
19:15 | End of the meeting
Synple Chem is a developer of new organic synthesis technologies. Our automated capsule-based synthesizers work analogously to capsule coffee makers - simply add the starting material and a commercially available, single-use, disposable reagent capsule, then with a single touch of a button, the product is generated, isolated and purified!
2nd EFMC-YSN MedChemBioOnline
Chairman
Dr Clemens Zwergel (Sapienza University of Rome, Italy)
Moderator
Mr Matic Proj (University of Ljubljana, Slovenia)
PROGRAMME:
- 17:00 | Opening
- 17:05 | Critical Targets and Drug Design to Combat Covid-19 | Abstract
Prof. Arun K. Ghosh (Purdue University, United States) - 17:50 | Integrated Drug Discovery within CRO Network Abstract | Video
Dr Luc Van Hijfte (MercachemSyncom, The Netherlands) - 18:00 | Stress Management for Mental Well-Being Abstract | Video
Mrs Anabel Jiménez (Education First, Switzerland) - 18:45 | Round Table discussion - "How to Deal with the Stressful Moments: PhD Defense, Job Interview, Team Management, etc" | Video
Dr Dave Alker (Consultant, United Kingdom)
Dr João António (University of Lisbon, Portugal)
Mrs Anabel Jiménez (Education First, Switzerland)
Prof. Antti Poso (University of Eastern Finland, Finland) - 19:15 | End of the meeting

MercachemSyncom is the leading mid-sized European drug-discovery CRO for solving your chemistry challenges, from small to medium-sized molecule hits, to the first GMP batches of identified clinical candidates. We blend vast scientific knowledge with inventiveness to make great leaps on your behalf. We go further to unlock new potential.
1st EFMC-YSN MedChemBioOnline
Chairman
Dr Michele Mari (Università degli Studi di Urbino Carlo Bo, Italy)
Moderator
Ms Pauline Zipfel (University of Caen Normandy, France)
PROGRAMME:
- 17.00 | The Chemistry and Biology of the Marine Macrolides Dactylolide and Zampanolide
Prof. Karl-Heinz Altmann (ETH Zürich, Switzerland) - 17.45 | DNA-Encoded Libraries for Academic Hit Discovery
Dr Alex Satz (WuXi Apptec, Switzerland) - 17.55 | 5 Rules for Effective Writing in the Sciences
Dr David Peralta (Editor-in-Chief, ChemMedChem, A Chemistry Europe Journal) - 18.45 | Round Table discussion - "Secrets of Scientific Writing - The Unwritten Rules"
Dr Yves P. Auberson (Novartis, Switzerland)
Prof. Maria-Laura Bolognesi (University of Bologna, Italy)
Prof. Stuart Conway (University of Oxford, United Kingdom)
Dr David Peralta (Editor-in-Chief, ChemMedChem, A Chemistry Europe Journal)
The event was generously sponsored by WuXi AppTec.

Established in December 2000, WuXi AppTec provides a broad portfolio of R&D and manufacturing services to advance discoveries and deliver groundbreaking treatments to patients. WuXi AppTec HitS Unit provides a one-stop Target-to-Hit services that enable companies in the pharmaceuticals, biotech and academics worldwide to seek premium drug discovery. With industry-leading capabilities such as protein science, biophysics, DNA-encoded library technology, and structure-based drug design, HitS is committed to drive toward the realization of the vision that every drug can be made and every disease can be treated.






